US SB4640 | 2019-2020 | 116th Congress
Status
Spectrum: Bipartisan Bill
Status: Introduced on September 22 2020 - 25% progression, died in committee
Action: 2020-09-22 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Pending: Senate Health, Education, Labor, And Pensions Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on September 22 2020 - 25% progression, died in committee
Action: 2020-09-22 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Pending: Senate Health, Education, Labor, And Pensions Committee
Text: Latest bill text (Introduced) [PDF]
Summary
Requires prescribers of controlled substances, as a condition of obtaining or renewing their registration with the Drug Enforcement Administration, to complete specified education or training on the prevention, treatment, and management of opioid-use and other substance-use disorders. This education and training shall also satisfy the training requirements currently needed to obtain waivers to prescribe certain medication-assisted treatments for opioid-use disorders in settings other than opioid treatment programs.
Title
MATE Act of 2020 Medication Access and Training Expansion Act of 2020
Sponsors
Sen. Michael Bennet [D-CO] | Sen. Susan Collins [R-ME] |
History
Date | Chamber | Action |
---|---|---|
2020-09-22 | Senate | Read twice and referred to the Committee on Health, Education, Labor, and Pensions. |
Same As/Similar To
HB4974 (Related) 2019-12-18 - Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.
Subjects
US Congress State Sources
Type | Source |
---|---|
Summary | https://www.congress.gov/bill/116th-congress/senate-bill/4640/all-info |
Text | https://www.congress.gov/116/bills/s4640/BILLS-116s4640is.pdf |